glp-1 candidates Currently approved, or soon to be evaluated, drug of GLP-1 Medications for Weight Loss:

It works by slowing gastric emptying, meaning food stays in the stomach longer, leading to better digestion and nutrient absorption

Takeaway The vision is for real-world patients on each of these drugs to be followed over the next two to four years to see what happens to their cardiac risk scores, and how that relates to their body mass index or other comorbidities

But accuracy matters more than convenience

When should Imodium not be taken

6a), a model in which tirzepatide, semaglutide and retatrutide showed only modest ability to prevent the establishment of obesity 38,39

Tara *Based on internal survey 416 GLP-1 users in 2025 **Based on survey responses of 166 participants in a 6-month clinical trial who had overweight or obesity, and were taking semaglutide/tirzepatide for weight loss within the WW Clinic Program and participating in the GLP-1 companion nutrition program